Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × nolatrexed × Clear all

NCT00012324 2013-06-26

Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms